Startups
Kesios, a spin-out from Imperial College London, was developing a novel oncology therapeutic for multiple myeloma. Kesios could not replicate the pre-clinical assays of the inventor and the company suspended further development work.
Overview
Location
United Kingdom, England, London
Total raised
$28.4M
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 8, 2014 | Kesios Therapeutics Raises £1.85M in Seed Funding | Kesios Therapeutics, a London, UK-based oncology drug discovery company, raised £1.85m in seed funding. Imperial Innovations Group plc (AIM: IVO) made the investment and now holds a 48.4% stake in Kesios. The company is using the funds to a... |
Reviews 0
FAQ about Kesios Therapeutics
How much funding has Kesios Therapeutics raised?
Kesios Therapeutics has raised $28.4M in total across 1 funding round.
What has the press written about Kesios Therapeutics?
Parsers VC has collected 2 articles mentioning Kesios Therapeutics, among them “Kesios Therapeutics Raises £1.85M in Seed Funding” (Oct 8, 2014).
Is Kesios Therapeutics still active?
Yes, Kesios Therapeutics is active; its latest activity on Parsers VC dates from Dec 2, 2015.